Prokidney Corp Stock Performance
| PROK Stock | USD 2.40 0.44 15.49% |
ProKidney Corp holds a performance score of 12 on a scale of zero to a hundred. The company holds a Beta of -0.56, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ProKidney Corp are expected to decrease at a much lower rate. During the bear market, ProKidney Corp is likely to outperform the market. Use ProKidney Corp value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on ProKidney Corp.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in ProKidney Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, ProKidney Corp disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (15.49) | Five Day Return 42.86 | Year To Date Return 40.35 | Ten Year Return (76.26) | All Time Return (76.26) |
Last Split Factor 1:1 | Last Split Date 2022-07-12 |
1 | Conversion by Darin Weber of 137073 shares of ProKidney Corp | 02/06/2024 |
2 | ProKidney to Participate in Jefferies Biotech on the Bay Summit | 02/29/2024 |
3 | Acquisition by Darin Weber of 117264 shares of ProKidney Corp at 1.61 subject to Rule 16b-3 | 03/01/2024 |
4 | Acquisition by Girolamo Todd C of 300000 shares of ProKidney Corp at 1.61 subject to Rule 16b-3 | 03/05/2024 |
5 | ProKidney Coverage Initiated by Analysts at Morgan Stanley - MarketBeat | 03/08/2024 |
6 | ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights | 03/21/2024 |
7 | ProKidney boosts leadership for phase 3 program clinical program | 03/25/2024 |
8 | Acquisition by Ernst Ulrich Peter Alfred of 335000 shares of ProKidney Corp at 1.6 subject to Rule 16b-3 | 04/01/2024 |
9 | Disposition of 84103 shares by Darin Weber of ProKidney Corp at 1.73 subject to Rule 16b-3 | 04/12/2024 |
10 | ProKidney Sees Large Volume Increase - MarketBeat | 04/15/2024 |
11 | ProKidney exec sells over 43k in company shares | 04/17/2024 |
| Begin Period Cash Flow | 490.3 M | |
| Free Cash Flow | -124.3 M |
ProKidney |
ProKidney Corp Relative Risk vs. Return Landscape
If you would invest 137.00 in ProKidney Corp on January 20, 2024 and sell it today you would earn a total of 103.00 from holding ProKidney Corp or generate 75.18% return on investment over 90 days. ProKidney Corp is currently generating 1.1472% in daily expected returns and assumes 7.4095% risk (volatility on return distribution) over the 90 days horizon. In different words, 65% of stocks are less volatile than ProKidney, and 78% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ProKidney Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProKidney Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ProKidney Corp, and traders can use it to determine the average amount a ProKidney Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1548
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PROK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.41 actual daily | 65 65% of assets are less volatile |
Expected Return
| 1.15 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 12 88% of assets perform better |
Based on monthly moving average ProKidney Corp is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProKidney Corp by adding it to a well-diversified portfolio.
ProKidney Corp Fundamentals Growth
ProKidney Stock prices reflect investors' perceptions of the future prospects and financial health of ProKidney Corp, and ProKidney Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProKidney Stock performance.
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 1.31 B | ||||
| Shares Outstanding | 61.62 M | ||||
| Price To Book | 91.32 X | ||||
| EBITDA | (148.35 M) | ||||
| Net Income | (35.47 M) | ||||
| Cash And Equivalents | 21.88 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 4.41 M | ||||
| Debt To Equity | 5.66 % | ||||
| Current Ratio | 0.74 X | ||||
| Book Value Per Share | (18.43) X | ||||
| Cash Flow From Operations | (90.07 M) | ||||
| Earnings Per Share | (0.57) X | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 420.55 M | ||||
| Retained Earnings | (1.14 B) | ||||
| Working Capital | 349.11 M | ||||
About ProKidney Corp Performance
To evaluate ProKidney Corp Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ProKidney Corp generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ProKidney Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ProKidney Corp market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ProKidney's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (0.08) | (0.09) | |
| Return On Capital Employed | (0.38) | (0.40) | |
| Return On Assets | (0.08) | (0.09) | |
| Return On Equity | 0.03 | 0.03 |
Things to note about ProKidney Corp performance evaluation
Checking the ongoing alerts about ProKidney Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ProKidney Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ProKidney Corp is way too risky over 90 days horizon | |
| ProKidney Corp appears to be risky and price may revert if volatility continues | |
| The company currently holds 4.41 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist ProKidney Corp until it has trouble settling it off, either with new capital or with free cash flow. So, ProKidney Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ProKidney Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ProKidney to invest in growth at high rates of return. When we think about ProKidney Corp's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (35.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a frail financial position based on the latest SEC disclosures | |
| Roughly 61.0% of ProKidney Corp shares are owned by institutional investors | |
| Latest headline from investing.com: ProKidney exec sells over 43k in company shares |
- Analyzing ProKidney Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ProKidney Corp's stock is overvalued or undervalued compared to its peers.
- Examining ProKidney Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ProKidney Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ProKidney Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ProKidney Corp's stock. These opinions can provide insight into ProKidney Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for ProKidney Stock analysis
When running ProKidney Corp's price analysis, check to measure ProKidney Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProKidney Corp is operating at the current time. Most of ProKidney Corp's value examination focuses on studying past and present price action to predict the probability of ProKidney Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProKidney Corp's price. Additionally, you may evaluate how the addition of ProKidney Corp to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is ProKidney Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.